secwatch.observer — SEC 8-K summary
======================================

Issuer:     Telomir Pharmaceuticals, Inc. (TELO)
CIK:        0001971532
Form:       8-K
Filed at:   2025-05-29T23:59:59+00:00
Accession:  0001641172-25-012785
Event type: other_material
Sentiment:  positive
Materiality: 0.55
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Telomir Pharmaceuticals reports Telomir-1 restores vision in AMD animal model
-----------------------------------------------------------------------------

- Telomir-1 improved central vision response and motion detection in AMD zebrafish model.
- Retinal layer regeneration observed: INL, GCL, IPL, OPL thickness increased.
- Reactive oxygen species reduced ~50% vs. untreated; 15% mortality in controls vs. 0% in treated.
- Results support continued advancement toward IND submission.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1971532/000164117225012785/0001641172-25-012785-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1971532/000164117225012785/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-012785

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer